Dihydrotanshinone Inhibits Hepatocellular Carcinoma by Suppressing the JAK2/STAT3 Pathway

Hu, X; Jiao, FZ; Zhang, L; Jiang, YA

Jiang, YA (corresponding author), Wuhan Univ, Renmin Hosp, Dept Infect Dis, Wuhan, Peoples R China.

FRONTIERS IN PHARMACOLOGY, 2021; 12 ():